Factor VIII

3 registered clinical trials studyying Factor VIII.

Status	Trial	Sponsor	Phase
Withdrawn	POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapi NCT04690322	University of Texas Southwestern Medical Center	Phase 4
Unknown	Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A NCT05628558	Groupe Maladies hémorragiques de Bretagne	—
Unknown	Personalized Prophylactic Treatment With Advate® in Severe or Moderate Haemophilia A Patients NCT02622646	Hospital Universitario La Fe	—